Clinical outcomes of myocardial bridging vs no myocardial bridging in patients with apical hypertrophic cardiomyopathy
Cardiology Feb 08, 2018
Zhai SS, et al. - Prevalence, as well as clinical impacts of myocardial bridging (MB) in patients with apical hypertrophic cardiomyopathy (AHCM), were determined. AHCM patients with MB vs those without MB exhibited more serious symptoms and a higher risk of cardiovascular (CV) events, however, CV mortality was similar in these 2 groups.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty -
Paid Market Research Surveys -
Case discussions, News & Journals' summaries
